Latest Headlines

  1. Granules India To Invest $35M Into Fairfax VA Manufacturing Facility

    Granules India Ltd., a vertically integrated pharmaceutical company, will invest $35 million into its wholly-owned subsidiary, Granules Pharmaceuticals Inc., to expand its pharmaceutical R&D and manufacturing capabilities in Fairfax County, Virginia.

  2. miRagen Therapeutics To Present New Clinical Trial Data For MRG-106, An Oligonucleotide Therapeutic Targeting microRNA-155, At The American Society Of Clinical Oncology Annual Meeting

    Miragen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of microRNA-targeted therapies, announced today that new interim results from its ongoing Phase 1 clinical study of MRG-106 will be presented on June 5, 2017 at the American Society of Clinical Oncology (ASCO) Annual Meeting being held June 2-6, 2017 in Chicago, Illinois.

  3. Sartorius Stedim Biotech Partners With Nova Biomedical

    Sartorius Stedim Biotech (SSB), a leading international supplier to the biopharmaceutical industry, recently announced an agreement with Nova Biomedical (Nova), a well-known US manufacturer of cell culture analyzers, to integrate their BioProfile FLEX2 into the ambr multi-parallel bioreactor systems for automated, at-line cell culture analytics.

  4. Peli BioThermal Unveils New Series 22 Universal System

    Peli BioThermal, the global name in cold chain, providing the broadest and most innovative range of temperature-controlled packaging solutions serving the life sciences industry, recently introduces Series 22 Universal for its Crēdo™ shippers.


  5. Vivaldi Biosciences Appoints Manfred Reiter, PHD As Senior Vice President, Manufacturing

    Vivaldi Biosciences Inc., a clinical-stage biotechnology company developing genetically attenuated live influenza vaccines for seasonal and pandemic influenza, recently announced the appointment of Manfred Reiter, PhD as Senior Vice President, Manufacturing. Dr. Reiter has responsibility for Vero cell-based production of Vivaldi’s deltaFLU live attenuated influenza vaccines (LAIVs), including process optimization, scale-up, and manufacture in compliance with global quality standards.

  6. PCI Clinical Services Announces Move-In Phase Of European Clinical Site Expansion

    Leading international pharmaceutical outsourcing services provider PCI Clinical Services (PCI) has announced the Practical Completion of its expanded Clinical Services Center of Excellence at Bridgend, UK and has commenced to moving into the expansion for progression to full validation.

  7. Pharmaceutical Contract Packaging Facility For Humidity-Sensitive Products

    Pharma Packaging Solutions is pleased to announce a new primary packaging suite which is designed to maintain low relative humidity levels. The turnkey contract packager is experienced in serving the pharmaceutical  industry with oral solid dose packaging solutions including bottling, blistering and cartoning.

  8. Tablet Compression Training Courses Announced For June, July And September

    Tablet Compression Resource, a division of Natoli Engineering Company, Inc., has announced the launch of new training courses in 2017 at their Long Island facility. These opportunities include a full-day tablet manufacturing seminar, as well as no-cost open houses for formulation troubleshooting, and Standard Operating Procedure (SOP) creation and optimization.

  9. Catalent Provides Commercial Manufacturing Of Lexicon Pharmaceuticals' Orphan Drug XERMELO Following FDA Approval

    Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, recently welcomed Lexicon Pharmaceuticals, Inc.’s announcement that its pioneering orphan drug, XERMELO™, has been approved by the U.S. Food and Drug Administration

  10. IDBS Extends Validated Service To The Cloud

    After The E-WorkBook Cloud launch earlier this year, IDBS has now enhanced its capabilities by adding a pre-qualified service to the suite, which has been designed to help organizations streamline their compliance processes for good practice (GxP) regulated systems.